Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  HIV Infection

  Free Subscription


12.10.2026

8 AIDS
2 AIDS Res Hum Retroviruses
1 Antimicrob Agents Chemother
1 BMJ
3 Clin Infect Dis
1 Drugs
3 HIV Med
4 J Acquir Immune Defic Syndr
1 J Am Acad Dermatol
1 J Clin Invest
2 J Infect Dis
2 J Virol
1 JAMA
1 Lancet
1 Nature
2 PLoS Comput Biol
6 PLoS One
1 PLoS Pathog


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AIDS

  1. DUARTE MJ, Tien PC, Ma Y, French AL, et al
    Higher plasma kynurenine-tryptophan ratio predicts incident hepatic fibrosis in women with HIV.
    AIDS. 2026 Oct 8. doi: 10.1097/QAD.0000000000004633.
    PubMed         Abstract available

  2. JOHN-STEWART G, Dyer J, Jiang W, Badia J, et al
    Consent understanding and willingness to participate in research among adolescents and young adults living with HIV.
    AIDS. 2026 Oct 8. doi: 10.1097/QAD.0000000000004638.
    PubMed         Abstract available

  3. ABRESCIA N, Maddaloni A, Molinaro G, D'Abbraccio M, et al
    Plasma-genital HIV-1 RNA discordance in women: early observations and biological interpretation in the U=U era.
    AIDS. 2026 Oct 8. doi: 10.1097/QAD.0000000000004634.
    PubMed         Abstract available

  4. BERENGUER J, Ryan P, Lutz T, Martin-Carbonero L, et al
    Adherence to European AIDS clinical society hepatitis B management guidelines in people with HIV: real-world evidence from Spain and Germany.
    AIDS. 2026 Oct 8. doi: 10.1097/QAD.0000000000004635.
    PubMed         Abstract available

  5. WINSTON A, Gohil J, Keegan M, Alagaratnam J, et al
    Tryptophan metabolomic profiling in persons with and without HIV.
    AIDS. 2026 Oct 8. doi: 10.1097/QAD.0000000000004639.
    PubMed         Abstract available

  6. CRESTA M, Brun A, Merlet P, Hamet G, et al
    Exercise testing and single-photon emission computed tomography myocardial perfusion imaging to detect silent coronary heart disease in people with HIV.
    AIDS. 2026 Oct 8. doi: 10.1097/QAD.0000000000004637.
    PubMed         Abstract available

  7. GOGINENI S, Nuwagaba G, Hooda M, Natukunda S, et al
    Traditional healers in HIV differentiated service delivery.
    AIDS. 2026 Oct 8. doi: 10.1097/QAD.0000000000004631.
    PubMed         Abstract available

  8. LI Y, Roan NR, Medvec T, Riddler S, et al
    Female sex is associated with continuous decline in intact HIV-1 proviruses during long-term antiretroviral therapy.
    AIDS. 2026 Oct 8. doi: 10.1097/QAD.0000000000004632.
    PubMed         Abstract available


    AIDS Res Hum Retroviruses

  9. EICHHOLZ K, Okoye AA, Varco-Merth BD, Gong J, et al
    Safety of Autologous Infusion of CER T Cells in Nonhuman Primates.
    AIDS Res Hum Retroviruses. 2026 Oct 7:8892229261490969.
    PubMed         Abstract available

  10. KA'E AC, Bouba Y, Ekwoge R, Ahmed A, et al
    Willingness to Participate in HIV Cure Research Among Young People Living with Perinatally Acquired HIV in the Centre Region of Cameroon: A Cross-Sectional Survey.
    AIDS Res Hum Retroviruses. 2026 Oct 7:8892229261495198.
    PubMed         Abstract available


    Antimicrob Agents Chemother

  11. NUSSBAUM JC, Pham MM, Vargo R, Liu Y, et al
    Open-label Phase 1 study to evaluate drug-drug interactions between ulonivirine and islatravir in adults without HIV.
    Antimicrob Agents Chemother. 2026 Oct 8:e0067626. doi: 10.1128/aac.00676.
    PubMed         Abstract available


    BMJ

  12. COZZOLINO A
    Turkey targets LGBTQI+ medical organisations, isolating arrested people with HIV.
    BMJ. 2026;395:e101051.
    PubMed        


    Clin Infect Dis

  13. DE LAZZARI E, Chivite I, Merino-Penas MJ, Laguno M, et al
    Interpreting Noninferiority in Risk-Stratified HIV Follow-up: Beyond a Single Margin.
    Clin Infect Dis. 2026 Oct 3:ciag625. doi: 10.1093.
    PubMed        

  14. CHOUGLE AZ, Chougle SZ
    Interpreting Post Hoc Noninferiority Analyses in Reduced-Frequency HIV Follow Up.
    Clin Infect Dis. 2026 Oct 3:ciag624. doi: 10.1093.
    PubMed        

  15. WOOD RC, Olson AM, Lochner KA, Dragovich RB, et al
    Tongue Swab Mycobacterium tuberculosis Quantitative Polymerase Chain Reaction for Community Screening of Asymptomatic Tuberculosis Versus Clinic-Based Triage of Symptomatic Tuberculosis.
    Clin Infect Dis. 2026 Oct 9:ciag443. doi: 10.1093.
    PubMed         Abstract available


    Drugs

  16. FANUCCHI LC, Eaton E, Van Sickels N, Lofwall MR, et al
    Infections and the Opioid Epidemic: Changing Epidemiology and Treatment Options.
    Drugs. 2026 Oct 4. doi: 10.1007/s40265-026-02364.
    PubMed         Abstract available


    HIV Med

  17. BLANKENBERGER J, Steffy TLF, Lee T, Makhesi T, et al
    HIV viral suppression in children and adolescents who transitioned from ritonavir-boosted lopinavir- to dolutegravir-based antiretroviral therapy in Lesotho.
    HIV Med. 2026 Oct 5. doi: 10.1111/hiv.70316.
    PubMed         Abstract available

  18. SMITH K, Locke M, Andersson E, Broddesson S, et al
    Beyond CD4 counts: Multi-biomarker assessment of estimated time since HIV-1 infection and risk factors for late diagnosis.
    HIV Med. 2026 Oct 6. doi: 10.1111/hiv.70314.
    PubMed         Abstract available

  19. KITONSA J, Komata R, Ssembajjwe W, Grint D, et al
    A systematic review of evidence on weight change following initiation of long-acting cabotegravir for the prevention or treatment of HIV.
    HIV Med. 2026 Oct 8. doi: 10.1111/hiv.70319.
    PubMed         Abstract available


    J Acquir Immune Defic Syndr

  20. LECATES A, Schwinne M, Yang M, Assi M, et al
    Comparing Structural Determinants, Psychosocial Factors, and Individual-Level Risk Indicators for Women's HIV Prevention in the Urban South.
    J Acquir Immune Defic Syndr. 2026 Oct 8. doi: 10.1097/QAI.0000000000003984.
    PubMed         Abstract available

  21. FAMA R, Sassoon SA, Muller-Oehring EM, Saranathan M, et al
    Postural instability in individuals living with HIV infection: Relations with thalamic nuclei volumes, peripheral neuropathy, age, and falls.
    J Acquir Immune Defic Syndr. 2026 Oct 8. doi: 10.1097/QAI.0000000000003983.
    PubMed         Abstract available

  22. ZIMBA R, Kelvin EA, Kulkarni S, Carmona J, et al
    Exploring provider preferences for HIV treatment support packages integrating long-acting injectable antiretroviral therapy in New York Ryan White Part A medical case management programs.
    J Acquir Immune Defic Syndr. 2026 Oct 7. doi: 10.1097/QAI.0000000000003978.
    PubMed         Abstract available

  23. CAIN D, Adhemar C, Howe K, Amin L, et al
    Correlates of confidence to utilize non-occupational Post-Exposure Prophylaxis (PEP) if needed among sexual minority men in relationships.
    J Acquir Immune Defic Syndr. 2026 Oct 5. doi: 10.1097/QAI.0000000000003979.
    PubMed         Abstract available


    J Am Acad Dermatol

  24. SMALE NE, Nguyen K, Mandal S, Friedman S, et al
    Kaposi Sarcoma Is No Longer Predominantly HIV-Associated: Findings from a Single-Center Retrospective Review.
    J Am Acad Dermatol. 2026 Oct 8:S0190-9622(26)03719.
    PubMed        


    J Clin Invest

  25. JAMIL R, Huibner S, Yang P, Nnamutete J, et al
    Impact of sexual debut on urethral immunology and microbiome in adolescent males from Rakai, Uganda.
    J Clin Invest. 2026 Oct 6:e208629. doi: 10.1172/JCI208629.
    PubMed         Abstract available


    J Infect Dis

  26. FREEMAN ML, Honerkamp-Smith G, Wells A, Clagett BM, et al
    Plasma Proteome Signature of Immune Inhibition is Associated with Cytomegalovirus in People with HIV-1.
    J Infect Dis. 2026 Oct 7:jiag498. doi: 10.1093.
    PubMed         Abstract available

  27. MAROTTI M, Epling BP, Angelova A, Segrist E, et al
    Evaluation of gut microbiota composition in elite controllers and antiretroviral-treated people with HIV after aspirin versus atorvastatin administration.
    J Infect Dis. 2026 Oct 9:jiag508. doi: 10.1093.
    PubMed         Abstract available


    J Virol

  28. ZHANG D, Han J, Liu C, Lu J, et al
    A four-amino-acid deletion in gp41 enhances HIV-1 CRF01_AE Cluster 4 pathogenicity and fusion inhibitor resistance.
    J Virol. 2026 Oct 5:e0115826. doi: 10.1128/jvi.01158.
    PubMed         Abstract available

  29. EYMARD ED, Yalcin D, Ngalamika O, Lidenge SJ, et al
    Humoral response against Epstein-Barr virus follows a strain-specific and HIV-driven pattern.
    J Virol. 2026 Oct 7:e0104326. doi: 10.1128/jvi.01043.
    PubMed         Abstract available


    JAMA

  30. ANDERER S
    Population Living With HIV Projected to Age in Coming Years.
    JAMA. 2026 Oct 9. doi: 10.1001/jama.2026.20016.
    PubMed        


    Lancet

  31. BEKKER LG, Neilan AM
    Closing the gap on mortality for adolescents living with HIV.
    Lancet. 2026;408:1402-1404.
    PubMed        


    Nature

  32. NOGRADY B
    'When prevention disappears, infections rise': can the world still end AIDS?
    Nature. 2026;658:S5-S7.
    PubMed        


    PLoS Comput Biol

  33. CELESTE CG, Sokolik CC, Gachunga W, Parker IK, et al
    Machine learning and Voronoi-based decision boundaries for Bacterial vaginosis to determine population- specific microbial interactions.
    PLoS Comput Biol. 2026;22:e1014767.
    PubMed         Abstract available

  34. LIU W, Shi Y, Guo X, Lou C, et al
    Repurposing ritonavir to induce proteasomal degradation of IE1 for inhibition of human cytomegalovirus replication.
    PLoS Comput Biol. 2026;22:e1014867.
    PubMed         Abstract available


    PLoS One

  35. TUSUBIRA AK, Ssemata AS, Katahoire AR, May C, et al
    Self-care practices of people living with HIV and hypertension or diabetes comorbidities in low-and-middle income countries: A systematic review.
    PLoS One. 2026;21:e0360076.
    PubMed         Abstract available

  36. AYANKU S, Hanu EK, Akuba L, Tetteh C, et al
    Seroprevalence and trends of transfusion-transmissible infections among blood donors in the Volta Region, Ghana: A four-year retrospective study.
    PLoS One. 2026;21:e0349548.
    PubMed         Abstract available

  37. LI X, Jorgensen D, Liu H, Nie Q, et al
    Global spread and evolutionary trajectories of HIV-1 CRF01_AE: Insights from phylogenetic analysis.
    PLoS One. 2026;21:e0360404.
    PubMed         Abstract available

  38. WILKINSON T, Fortuin S, Hesseling AC, Schaaf HS, et al
    Health system and household costs of preventive treatment delivery for children exposed to multidrug-resistant tuberculosis in South Africa.
    PLoS One. 2026;21:e0336561.
    PubMed         Abstract available

  39. CHIRIMO R, Zhou DT, Mudzviti T, Ruredzo IM, et al
    Burden and determinants of hyperglycaemia and dyslipidaemia in Zimbabwean adults living with HIV on dolutegravir-based first-line antiretroviral therapy: A cross-sectional study.
    PLoS One. 2026;21:e0359196.
    PubMed         Abstract available

  40. LU X, Zelnick J, Zhao M, Cummings M, et al
    Temporal proximity to counseling is associated with longitudinal bedaquiline and antiretroviral therapy adherence in multidrug-resistant tuberculosis and HIV treatment.
    PLoS One. 2026;21:e0355696.
    PubMed         Abstract available


    PLoS Pathog

  41. ZHANG Y, Wang P, Zhang J, Wang Y, et al
    KSHV K15 genetic heterogeneity is associated with Kaposi sarcoma aggressiveness through modulation of the host inflammatory microenvironment.
    PLoS Pathog. 2026;22:e1014615.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum